Komori
Medikit (7749) · RiskRestated

Risk of Intellectual Property Rights Infringement and Disputes

First written in FY2016. 24 of 26 entries say "Restated". Latest entry: FY2025.

26entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2021-Q3RestatedFY2022-Q1 – FY20252016: 320162017: 320172018: 420182019: 320192020: 220202021: 420212022: 420222023: 120232024: 120242025: 12025
Same theme, other companies
Third-Party and Own Intellectual Property Rights Infringement RiskA theme 408 companies write about · 408 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 9 of 58 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 409 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「With respect to the development, manufacture, and sale of products, the Group has appointed dedicated personnel and seeks to secure intellectual property rights in order to maintain its competitive advantage. It also seeks to prevent infringement of the intellectual property rights of other companies that may be related to its products.」

    The risks of pressure from similar products due to insufficient protection of the Group's own intellectual property, and of third-party intellectual property infringement and litigation, together with the response by dedicated personnel, continue.
  2. FY2024-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  3. FY2024-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  4. FY2023-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  5. FY2023-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  6. FY2022RestatedAnnual report

    「If the Group were unable to adequately secure its own intellectual property rights and came under pressure from similar products, or if it were suspected of infringing another company's intellectual property rights and the matter developed into litigation, the Group's results could be affected depending on the nature and outcome of the matter. …The Group has appointed dedicated personnel, seeks to secure intellectual property rights, and also seeks to prevent infringement of the intellectual property rights of other companies that may be related to its products.」

    The risks of pressure from similar products due to insufficient protection of the Group's own intellectual property, and of third-party intellectual property infringement and litigation, together with the response by dedicated personnel, continue.
  7. FY2022-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  8. FY2022-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  9. FY2022-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  10. FY2021ReframedAnnual report

    「If the Group were unable to adequately secure its own intellectual property rights and came under pressure from similar products, or if it were suspected of infringing another company's intellectual property rights and the matter developed into litigation, the Group's results could be affected depending on the nature and outcome of the matter.」

    The risk presentation has expanded from the previous risk of infringing third-party intellectual property and litigation to include pressure from similar products resulting from insufficient protection of the Group's own intellectual property. The appointment of dedicated personnel is also disclosed.
  11. FY2021-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  12. FY2021-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  13. FY2020-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  14. FY2020-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  15. FY2020-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  16. FY2019-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  17. FY2019-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  18. FY2019-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  19. FY2018RestatedAnnual report

    「With respect to the development, manufacture, and sale of products, the Group seeks to secure intellectual property rights in order to maintain its competitive advantage, and also seeks to prevent infringement of the intellectual property rights of other companies that may be related to its products. However, if infringement occurs, it could lead to litigation, which could affect the Group's results.」

    The Group's securing of its own intellectual property, prevention of infringement of third-party intellectual property, and the possibility of litigation in the event of infringement are reiterated.
  20. FY2018-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  21. FY2018-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  22. FY2018-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no new developments or significant changes.
  23. FY2017-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  24. FY2017-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  25. FY2017-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The risk of intellectual property infringement and litigation is reaffirmed through a comprehensive statement that there have been no significant changes.
  26. FY2016First statedAnnual report

    「With respect to the development, manufacture, and sale of products, the Group seeks to secure intellectual property rights in order to maintain its competitive advantage, and also seeks to prevent infringement of the intellectual property rights of other companies that may be related to its products. However, if infringement occurs, it could lead to litigation, which could affect the Group's results.」

    The Group seeks to secure its own rights and prevent infringement of the rights of other companies, while indicating the possibility of litigation if infringement occurs.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medikit's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.